AIC
BSX icon

Aurora Investment Counsel’s Boston Scientific BSX Stock Holding History

Aurora Investment Counsel’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.87M Buy
+43,857
New +$2.38M 0.96% 51

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Aurora Investment Counsel's BSX Position: Q2 2026 in Review

Aurora Investment Counsel opened a new position in Boston Scientific (BSX) in Q2 2026: 43,857 shares worth $1.87M. The stake represents 0.96% of the portfolio and ranks #51 among its holdings.

1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Aurora Investment Counsel held 43,857 shares of Boston Scientific worth $1.87M as of Q2 2026.
  • Boston Scientific was a new Aurora Investment Counsel position in Q2 2026.
  • Boston Scientific made up 0.96% of Aurora Investment Counsel's portfolio in Q2 2026, its #51 holding.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Aurora Investment Counsel's 13F filing for Q2 2026, filed 10 Aug 2026.